Research & Lifestyle
Posted on 23 April 2008
If proton pump inhibitors fail to control the symptoms of gastro-oesophageal reflux disease, current standard management is to double the drug dose, despite limited therapeutic gain. An American clinical trial has compared this...
Categories
Archive
- August 2011 (1)
- April 2010 (1)
- January 2010 (5)
- December 2009 (2)
- November 2009 (2)
- September 2009 (1)
- April 2009 (1)
- March 2009 (6)
- January 2009 (1)
- December 2008 (1)
- September 2008 (2)
- July 2008 (1)
- June 2008 (17)
- May 2008 (22)
- April 2008 (44)
